ROGER D DANSEY
CIK 1741836 · President, R&D & CMO · last filed 2026-05-21
ROGER D DANSEY is a President, R&D & CMO who has filed 66 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for INO, was dated May 21, 2026. Across all open-market trades the lifetime net is −$35.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $72.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$72.7K
5
66
-$35.49M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INO | Director | 8,916 | $1.10 | $9.8K | $0 | 8 | 2026-05-21 |
| NRIX | Director | — | $16.95 | — | $0 | 2 | 2026-05-15 |
| BCYC | Director | 15,532 | $4.05 | $62.9K | $0 | 2 | 2026-01-06 |
| Kronos Bio, Inc. (KRON) Delisted | Director | — | $0.88 | — | $0 | 4 | 2025-06-20 |
| Seagen Inc. (SGEN) Delisted | President, R&D & CMO | 0 | $228.74 | $0 | -$35.49M | 50 | 2023-12-15 |
Recent Filings
66 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-21 | INO | Grant (A) | — | $0 | EDGAR |
| 2026-05-15 | NRIX | Grant (A) | — | $0 | EDGAR |
| 2026-01-06 | BCYC | Grant (A) | +3,032 | $0 | EDGAR |
| 2025-11-10 | NRIX | Grant (A) | — | $0 | EDGAR |
| 2025-09-10 | BCYC | Grant (A) | +12,500 | $0 | EDGAR |
| 2025-06-20 | Kronos Bio, Inc. (KRON) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-05-21 | INO | Exer (M) | +2,167 | $0 | EDGAR |
| 2024-06-26 | Kronos Bio, Inc. (KRON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-22 | INO | Grant (A) | — | $0 | EDGAR |
| 2024-05-16 | INO | Exer (M) | +2,166 | $0 | EDGAR |